Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
AIDS Dementia Complex D015526 4 associated lipids
Neoplasms, Germ Cell and Embryonal D009373 4 associated lipids
Burns, Inhalation D002059 4 associated lipids
Shock, Traumatic D012774 4 associated lipids
Hypertrophy, Right Ventricular D017380 4 associated lipids
Strongylida Infections D017206 5 associated lipids
Liver Failure D017093 5 associated lipids
Neoplastic Cells, Circulating D009360 5 associated lipids
Hepatitis, Alcoholic D006519 5 associated lipids
Granulomatosis with Polyangiitis D014890 5 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Yamanaka S et al. Putative mechanism of hypotensive action of platelet-activating factor in dogs. 1992 Circ. Res. pmid:1568300
Shimada T et al. Platelet-activating factor acts on cortisol secretion by perfused guinea-pig adrenals via calcium-/phospholipid-dependent mechanisms. 2005 J. Endocrinol. pmid:15684346
Yasu T et al. Activated leukocytes and endothelial cells enhance retention of ultrasound contrast microspheres containing perfluoropropane in inflamed venules. 2005 Int. J. Cardiol. pmid:15686774
Koch E Inhibition of platelet activating factor (PAF)-induced aggregation of human thrombocytes by ginkgolides: considerations on possible bleeding complications after oral intake of Ginkgo biloba extracts. 2005 Phytomedicine pmid:15693702
Jantan I et al. Platelet-activating factor (PAF) receptor-binding antagonist activity of Malaysian medicinal plants. 2005 Phytomedicine pmid:15693713
Kawata H et al. Evidence for the role of neutrophils in reperfusion injury after cold cardioplegic ischemia in neonatal lambs. 1992 J. Thorac. Cardiovasc. Surg. pmid:1569774
Grimminger F et al. Ligand-operated synthesis of 4-series and 5-series leukotrienes in human neutrophils: critical dependence on exogenous free fatty acid supply. 1992 Mol. Pharmacol. pmid:1569925
Fell JM Neonatal inflammatory intestinal diseases: necrotising enterocolitis and allergic colitis. 2005 Early Hum. Dev. pmid:15707723
Schaloske RH et al. Molecular characterization of the lipopolysaccharide/platelet activating factor- and zymosan-induced pathways leading to prostaglandin production in P388D1 macrophages. 2005 Biochim. Biophys. Acta pmid:15708354
El-Medany A et al. Attenuation of bleomycin-induced lung fibrosis in rats by mesna. 2005 Eur. J. Pharmacol. pmid:15713430
Fujimura K et al. Role of endogenous platelet-activating factor in caerulein-induced acute pancreatitis in rats: protective effects of a PAF-antagonist. 1992 Mar-Apr J. Gastroenterol. Hepatol. pmid:1571504
Ninio E Phospholipid mediators in the vessel wall: involvement in atherosclerosis. 2005 Curr Opin Clin Nutr Metab Care pmid:15716789
Leong LL et al. Effect of WEB 2086 on myocardial infarct size and regional blood flow in the dog. 1992 Cardiovasc. Res. pmid:1571932
Tippins JR et al. WEB 2086 inhibits neutrophil dependent increases in coronary resistance in blood perfused rabbit heart. 1992 Cardiovasc. Res. pmid:1571936
Evans L et al. A pharmacokinetic/pharmacodynamic model for a platelet activating factor antagonist based on data arising from Phase I studies. 2005 J. Pharm. Pharmacol. pmid:15720781
Lin P et al. Lysophosphatidylcholine modulates neutrophil oxidant production through elevation of cyclic AMP. 2005 J. Immunol. pmid:15728511
Vardar S et al. Therapeutic versus prophylactic plus therapeutic administration of omega-3 fatty acid on endotoxin-induced periodontitis in rats. 2004 J. Periodontol. pmid:15732866
Zinchuk O et al. Direct action of platelet activating factor (PAF) induces eosinophil accumulation and enhances expression of PAF receptors in conjunctivitis. 2005 Mol. Vis. pmid:15735601
Phenekos C et al. Effect of gliclazide on platelet-activating factor-induced platelet aggregation in patients with non-insulin-dependent diabetes mellitus. 1992 Metab. Clin. Exp. pmid:1574012
Lang PA et al. Stimulation of erythrocyte ceramide formation by platelet-activating factor. 2005 J. Cell. Sci. pmid:15741229
Jantan I et al. Inhibitory effects of compounds from Zingiberaceae species on platelet activating factor receptor binding. 2004 Phytother Res pmid:15742349
Grigoriou O et al. Effect of sperm treatment with exogenous platelet-activating factor on the outcome of intrauterine insemination. 2005 Fertil. Steril. pmid:15749490
Nathan N et al. Variations in blood platelet-activating-factor levels after protamine reversal of heparin in humans. 1992 Acta Anaesthesiol Scand pmid:1574976
Satoh K et al. Increased levels of blood platelet-activating factor (PAF) and PAF-like lipids in patients with ischemic stroke. 1992 Acta Neurol. Scand. pmid:1574985
Sanwick JM et al. Human spermatozoa produce C16-platelet-activating factor. 1992 Arch. Biochem. Biophys. pmid:1575513
Cabré F et al. Differential hydrolysis of 1-alkyl-2-acyl and diacylglycerophosphocholines by human and non-human phospholipases A2. 1992 Biochim. Biophys. Acta pmid:1576169
Kumar S and Sharma A Platelet activating factor improves the in vitro penetration of zona free hamster eggs by buffalo (Bubalus bubalis) spermatozoa. 2005 Theriogenology pmid:15763101
Tsuri T et al. A novel class of platelet activating factor (PAF) antagonists. II. Modification of the 2-position of the glycerol backbone of PAF-sulfonamide isosteres. 1992 Chem. Pharm. Bull. pmid:1576692
Yatomi Y et al. Phosphorylation of the inhibitory guanine-nucleotide-binding protein as a possible mechanism of inhibition by protein kinase C of agonist-induced Ca2+ mobilization in human platelet. 1992 Eur. J. Biochem. pmid:1576985
Klementsson H and Andersson M Eosinophil chemotactic activity of topical PAF on the human nasal mucosa. 1992 Eur. J. Clin. Pharmacol. pmid:1577048
Nacken W et al. S100A9 deficiency alters adenosine-5'-triphosphate induced calcium signalling but does not generally interfere with calcium and zinc homeostasis in murine neutrophils. 2005 Int. J. Biochem. Cell Biol. pmid:15778088
Minnear FL et al. Sphingosine 1-phosphate prevents platelet-activating factor-induced increase in hydraulic conductivity in rat mesenteric venules: pertussis toxin sensitive. 2005 Am. J. Physiol. Heart Circ. Physiol. pmid:15778280
Perry SW et al. HIV-1 transactivator of transcription protein induces mitochondrial hyperpolarization and synaptic stress leading to apoptosis. 2005 J. Immunol. pmid:15778398
Bazan HE Cellular and molecular events in corneal wound healing: significance of lipid signalling. 2005 Exp. Eye Res. pmid:15781273
Cassatella MA et al. IL-8 production by human polymorphonuclear leukocytes. The chemoattractant formyl-methionyl-leucyl-phenylalanine induces the gene expression and release of IL-8 through a pertussis toxin-sensitive pathway. 1992 J. Immunol. pmid:1578146
Wissner A et al. Analogues of platelet activating factor. 6. Mono- and bis-aryl phosphate antagonists of platelet activating factor. 1992 J. Med. Chem. pmid:1578493
Ishiura Y et al. In vivo PAF-induced airway eosinophil accumulation reduces bronchial responsiveness to inhaled histamine. 2005 Prostaglandins Other Lipid Mediat. pmid:15789611
Gaudreault E et al. Involvement of leukotriene B4 receptor 1 signaling in platelet-activating factor-mediated neutrophil degranulation and chemotaxis. 2005 Prostaglandins Other Lipid Mediat. pmid:15789613
Calcerrada MC et al. Selective translocation of protein kinase c isozymes by PAF in rabbit platelets. 2005 Prostaglandins Other Lipid Mediat. pmid:15789614
O'Neill C The role of paf in embryo physiology. 2005 May-Jun Hum. Reprod. Update pmid:15790601
Hudry-Clergeon H et al. Platelet-activating factor increases VE-cadherin tyrosine phosphorylation in mouse endothelial cells and its association with the PtdIns3'-kinase. 2005 FASEB J. pmid:15791001
Ersoy B et al. The role of platelet-activating factor in pathogenesis of type 1 diabetes. 2005 Diabetes Care pmid:15793212
Asai Y Formation of spherical micelles composed of the novel platelet activating factor receptor antagonist, E5880. 2005 Pharmazie pmid:15801673
Fulkerson PC et al. CXCL9 inhibits eosinophil responses by a CCR3- and Rac2-dependent mechanism. 2005 Blood pmid:15802529
Adamson LM et al. Release of anti-PAF activity from PAF-binding human ovarian cancer cells in culture. 1992 Mar-Apr Anticancer Res. pmid:1580546
Echazarreta AL et al. Lack of systemic oxidative stress during PAF challenge in mild asthma. 2005 Respir Med pmid:15823446
Sheppard FR et al. Clinically relevant osmolar stress inhibits priming-induced PMN NADPH oxidase subunit translocation. 2005 J Trauma pmid:15824651
Leveau P et al. Severity of pancreatitis-associated gut barrier dysfunction is reduced following treatment with the PAF inhibitor lexipafant. 2005 Biochem. Pharmacol. pmid:15826603
Dorsch W et al. Antiasthmatic effects of Galphimia glauca, gallic acid, and related compounds prevent allergen- and platelet-activating factor-induced bronchial obstruction as well as bronchial hyperreactivity in guinea pigs. 1992 Int. Arch. Allergy Immunol. pmid:1582692
Bates EJ et al. Inhibition of neutrophil respiratory burst and degranulation responses to platelet-activating factor by antagonists WEB 2086, CV 6209 and CV 3988. 1992 Int. Arch. Allergy Immunol. pmid:1582698
Sipka S et al. Histamine potentiates human platelet aggregation induced by platelet-activating factor. 1992 Int. Arch. Allergy Immunol. pmid:1582704
Iwama T et al. Inhibitory effect of NZ-107 on anaphylactic bronchoconstriction in guinea pigs and rats. 1992 Int. Arch. Allergy Immunol. pmid:1582710
Vardar S et al. Individual and combined effects of selective cyclooxygenase-2 inhibitor and omega-3 fatty acid on endotoxin-induced periodontitis in rats. 2005 J. Periodontol. pmid:15830643
Alloatti G et al. Platelet-activating factor (PAF) induces platelet/neutrophil co-operation during myocardial reperfusion. 1992 J. Mol. Cell. Cardiol. pmid:1583699
Iida H et al. Effects of the platelet-activating factor antagonists CV-6209 and CV-3988 on nephrotoxic serum nephritis in the rat. 1992 Nephron pmid:1584324
Furukawa M et al. Evidence of platelet-activating factor in nasal polyps. 1992 ORL J. Otorhinolaryngol. Relat. Spec. pmid:1584590
Ko HM et al. Involvement of matrix metalloproteinase-9 in platelet-activating factor-induced angiogenesis. 2005 FEBS Lett. pmid:15848174
Orevi M et al. A potent inhibitor of platelet activating factor from the saliva of the leech Hirudo medicinalis. 1992 Prostaglandins pmid:1584997
O'Neill C et al. Outcome of pregnancies resulting from a trial of supplementing human IVF culture media with platelet activating factor. 1992 Reprod. Fertil. Dev. pmid:1585005
Hardy P et al. New insights into the retinal circulation: inflammatory lipid mediators in ischemic retinopathy. 2005 Prostaglandins Leukot. Essent. Fatty Acids pmid:15850712
Schram MT et al. Advanced glycation end products are associated with pulse pressure in type 1 diabetes: the EURODIAB Prospective Complications Study. 2005 Hypertension pmid:15851628
Boccellino M et al. Platelet-activating factor regulates cadherin-catenin adhesion system expression and beta-catenin phosphorylation during Kaposi's sarcoma cell motility. 2005 Am. J. Pathol. pmid:15855650
Owen JS et al. Stress-induced platelet-activating factor synthesis in human neutrophils. 2005 Biochim. Biophys. Acta pmid:15863359
Göggel R and Uhlig S The inositol trisphosphate pathway mediates platelet-activating-factor-induced pulmonary oedema. 2005 Eur. Respir. J. pmid:15863642
Martínez-Cócera C et al. Rupatadine 10 mg and cetirizine 10 mg in seasonal allergic rhinitis: a randomised, double-blind parallel study. 2005 J Investig Allergol Clin Immunol pmid:15864879
Tool AT et al. Release of platelet-activating factor is important for the respiratory burst induced in human eosinophils by opsonized particles. 1992 Blood pmid:1586719
Okada C et al. Effect of terfenadine on neutrophil and eosinophil chemotactic activities after inhalation of platelet-activating factor in vivo and on neutrophil chemotaxis in vitro. 1992 Int. Arch. Allergy Immunol. pmid:1587633
Suda H et al. Effects of NZ-107 on bronchoconstriction in guinea pigs. 1992 Int. Arch. Allergy Immunol. pmid:1587634
Chand N et al. Inhibition of aeroallergen-induced bronchial eosinophilia by azelastine in guinea pigs. 1992 Int. Arch. Allergy Immunol. pmid:1587636
Yeh JH et al. 2-O-methyl PAF as a Ca2+ mobilizer in Madin Darby canine kidney cells. 2005 Life Sci. pmid:15878360
Raible DG et al. Mast cell mediators prostaglandin-D2 and histamine activate human eosinophils. 1992 J. Immunol. pmid:1588043
Medvedev IN and GromnatsiÄ­ NI [The influence of nebivolol on thrombocyte aggregation in patients with arterial hypertension with metabolic sydrome]. 2005 Klin Med (Mosk) pmid:15881638
Rastelli VM et al. Influence of insulin on the microvascular response to inflammatory mediators in neonatal streptozotocin diabetic rats. 2005 Inflamm. Res. pmid:15883740
Cheng L et al. Platelet-activating factor and prostaglandin E2 impair esophageal ACh release in experimental esophagitis. 2005 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:15890711
Qu XW et al. Tetrahydrobiopterin prevents platelet-activating factor-induced intestinal hypoperfusion and necrosis: Role of neuronal nitric oxide synthase. 2005 Crit. Care Med. pmid:15891335
Dunoyer-Geindre S et al. PAF acether release on antigenic challenge. A method for the investigation of drug allergic reactions. 1992 Allergy pmid:1590567
Joseph R and Han E Amyloid beta-protein fragment 25-35 causes activation of cytoplasmic calcium in neurons. 1992 Biochem. Biophys. Res. Commun. pmid:1590803
Gilli UO et al. Human polymorphonuclear neutrophils are recruited by porcine chemokines acting on CXC chemokine receptor 2, and platelet-activating factor. 2005 Transplantation pmid:15912099
Kasamo M et al. In vitro prostaglandin release from and platelet-activating factor accumulation in isolated endometrial cells from pregnant and pseudopregnant rabbits. 1992 Biol. Reprod. pmid:1591338
Biancone L et al. Platelet-activating factor biosynthesis by cultured mesangial cells is modulated by proteinase inhibitors. 1992 J. Am. Soc. Nephrol. pmid:1591364
Lai CK and Holgate ST Stimulation of human airway epithelial cells by platelet activating factor (PAF) and arachidonic acid produces 15-hydroxyeicosatetraenoic acid (15-HETE) capable of contracting bronchial smooth muscle. 1992 Pulm Pharmacol pmid:1591466
Park EJ et al. Dietary ganglioside decreases cholesterol content, caveolin expression and inflammatory mediators in rat intestinal microdomains. 2005 Glycobiology pmid:15917432
Chen LW et al. Different pathways leading to activation of extracellular signal-regulated kinase and p38 MAP kinase by formyl-methionyl-leucyl-phenylalanine or platelet activating factor in human neutrophils. 2005 J. Biomed. Sci. pmid:15917990
Goldring WP et al. Novel phomactin analogues as PAF receptor ligands. 2005 Bioorg. Med. Chem. Lett. pmid:15922596
Ding Z et al. Mechanisms of endothelial cell-dependent leukocyte adhesion stimulated by platelet-activating factor. 1992 Inflammation pmid:1592489
Tombul T et al. Hemostatic markers and platelet aggregation factors as predictive markers for type of stroke and neurological disability following cerebral infarction. 2005 J Clin Neurosci pmid:15925775
Mansour E et al. Attenuation of platelet-activating factor-induced airway responses with methylprednisolone succinate in sheep. 1992 J. Appl. Physiol. pmid:1592746
Vinson SM et al. Neutrophil adherence to bladder microvascular endothelial cells following platelet-activating factor acetylhydrolase inhibition. 2005 J. Pharmacol. Exp. Ther. pmid:15937147
Estellés R et al. Effect of boldine, secoboldine, and boldine methine on angiotensin II-induced neutrophil recruitment in vivo. 2005 J. Leukoc. Biol. pmid:15944212
Zhao T and Bokoch GM Critical role of proline-rich tyrosine kinase 2 in reversion of the adhesion-mediated suppression of reactive oxygen species generation by human neutrophils. 2005 J. Immunol. pmid:15944312
Nagata M et al. Effect of the cysteinyl leukotriene antagonist pranlukast on transendothelial migration of eosinophils. 2005 Int. Arch. Allergy Immunol. pmid:15947477
McLarnon JG et al. Perturbations in calcium-mediated signal transduction in microglia from Alzheimer's disease patients. 2005 J. Neurosci. Res. pmid:15948178
Lang KS et al. Mechanisms of suicidal erythrocyte death. 2005 Cell. Physiol. Biochem. pmid:15956782
Kita Y et al. A multiplex quantitation method for eicosanoids and platelet-activating factor using column-switching reversed-phase liquid chromatography-tandem mass spectrometry. 2005 Anal. Biochem. pmid:15958190
Fang YH et al. [Relationship between serum vWF and PAF in type 2 diabetic patients and diabetic nephropathy]. 2005 Di Yi Jun Yi Da Xue Xue Bao pmid:15958323
Souza DG and Teixeira MM The balance between the production of tumor necrosis factor-alpha and interleukin-10 determines tissue injury and lethality during intestinal ischemia and reperfusion. 2005 Mem. Inst. Oswaldo Cruz pmid:15962100
Castro Faria Neto HC et al. Regulating inflammation through the anti-inflammatory enzyme platelet-activating factor-acetylhydrolase. 2005 Mem. Inst. Oswaldo Cruz pmid:15962103
White DC et al. Feasibility of assessment of regulatory lipids in breath condensate as potential presymptomatic harbingers of pulmonary pathobiology. 2005 J. Microbiol. Methods pmid:15963585
Joly F et al. Heterogeneity of arachidonate and paf-acether precursor pools in mast cells. 1992 Biochim. Biophys. Acta pmid:1596519
Jeon SY et al. Rat model of platelet-activating factor-induced rhinosinusitis. 2005 Ann. Otol. Rhinol. Laryngol. pmid:15966528